Kathryn is the co-founder and Chief Scientific Officer at Engage Bio. Kathryn obtained her PhD in Chemical and Biomolecular Engineering at UC Berkeley. Kathryn then spent 2 years working in therapeutic antibody development at Bayer before joining Harpoon Therapeutics as one of their earliest hires. At Harpoon, Kathryn helped advance four bispecific T cell engagers into the clinic.